Literature DB >> 32045014

The dispensing of psychotropic medicines to older people before and after they enter residential aged care.

Stephanie L Harrison1,2, Janet K Sluggett1,3, Catherine Lang1, Craig Whitehead4, Maria Crotty5, Megan Corlis6, Steven L Wesselingh7, Maria C Inacio1,8.   

Abstract

OBJECTIVE: To examine the prevalence of psychotropic medicine dispensing before and after older people enter residential care.
DESIGN: Retrospective national cohort study; analysis of Registry of Senior Australians (ROSA) data. SETTING, PARTICIPANTS: All concession card-holding residents of government-subsidised residential aged care facilities in Australia who entered residential care for at least three months between 1 April 2008 and 30 June 2015. MAIN OUTCOME MEASURES: Proportions of residents dispensed antipsychotic, benzodiazepine, or antidepressant medicines during the year preceding and the year after commencing residential care, by quarter.
RESULTS: Of 322 120 included aged care residents, 68 483 received at least one antipsychotic (21.3%; 95% CI, 21.1-21.4%), 98 315 at least one benzodiazepine (30.5%; 95% CI, 30.4-30.7%), and 122 224 residents at least one antidepressant (37.9%; 95% CI, 37.8-38.1%) during their first three months of residential care; 31 326 of those dispensed antipsychotics (45.7%), 38 529 of those dispensed benzodiazepines (39.2%), and 25 259 residents dispensed antidepressants (19.8%) had not received them in the year preceding their entry into care. During the first three months of residential care, the prevalence of antipsychotic (prevalence ratio [PR], 3.37; 95% CI, 3.31-3.43) and antidepressant dispensing (PR, 1.05; 95% CI, 1.04-1.07) were each higher for residents with than for those without dementia; benzodiazepine dispensing was similar for both groups (PR, 1.01; 95% CI, 0.99-1.02).
CONCLUSIONS: Dispensing of psychotropic medicines to older Australians is high before they enter residential care but increases markedly soon after entry into care. Non-pharmacological behavioural management strategies are important for limiting the prescribing of psychotropic medicines for older people in the community or in residential care.
© 2020 AMPCo Pty Ltd.

Entities:  

Keywords:  Antidepressive agents; Antipsychotic agents; Dementia

Year:  2020        PMID: 32045014     DOI: 10.5694/mja2.50501

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study.

Authors:  Janet K Sluggett; Gillian E Caughey; Tracy Air; Max Moldovan; Catherine Lang; Grant Martin; Stephen R Carter; Shane Jackson; Andrew C Stafford; Steve L Wesselingh; Maria C Inacio
Journal:  BMC Geriatr       Date:  2022-06-08       Impact factor: 4.070

Review 2.  Limiting antipsychotic drugs in dementia.

Authors:  Stephen Macfarlane; Colm Cunningham
Journal:  Aust Prescr       Date:  2021-02-01

3.  What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators.

Authors:  Amalie Elisabeth Moth; Pernille Hølmkjær; Anne Holm; Maarten Pieter Rozing; Gritt Overbeck
Journal:  Drugs Aging       Date:  2021-07-07       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.